Literature DB >> 23803722

A novel risk-adjusted nomogram for rectal cancer surgery outcomes.

Maria C Russell1, Y Nancy You, Chung-Yuan Hu, Janice N Cormier, Barry W Feig, John M Skibber, Miguel A Rodriguez-Bigas, Heidi Nelson, George J Chang.   

Abstract

IMPORTANCE: The circumferential resection margin is the primary determinant of local recurrence and a major factor in survival in rectal cancer. Neither chemotherapy nor chemoradiation compensates for a margin positive for cancer.
OBJECTIVE: To identify treatment-related factors associated with hospital margin-positive resection and to develop a tool that could be used by individual hospitals to assess their outcomes based on their unique mix of patient and tumor characteristics.
DESIGN: Retrospective review of the National Cancer Data Base, 1998-2007. SETTINGS: Community and academic/research hospitals. PARTICIPANTS: Individuals with histologically confirmed localized rectal/rectosigmoid adenocarcinoma. EXPOSURE: All individuals underwent radical resection for rectal cancer with or without neoadjuvant therapy. MAIN OUTCOMES AND MEASURES: Rate of margin positivity determined and adjusted for patient- and tumor-related factors to calculate expected margin positivity per hospital. An observed to expected ratio was calculated based on patient- and tumor-related factors to identify treatment-associated variation.
RESULTS: The overall margin-positive resection rate was 5.2%. Patients with margins positive for cancer were more likely to be older, male, and African American; not have private insurance; and have their cancer diagnosed later in the study period. Associated tumor-related factors include rectal location, higher American Joint Committee on Cancer stage, signet/mucinous histology, and poor/undifferentiated grade. Among hospitals that were significantly low outliers, 47% were comprehensive community hospitals, and 43.9% were academic/research hospitals; of those that were significantly high outliers, 52.3% were comprehensive community hospitals, and 17.8% were academic/research hospitals. High-volume centers made up 80% of significantly low outlier hospitals and 17% of significantly high outlier hospitals. The rates of chemotherapy and radiation were similar, but low outlier hospitals gave more neoadjuvant radiation (26.3% vs 17%). CONCLUSIONS AND RELEVANCE: After adjustment for patient- and tumor-related factors, we identified both low and high outlier hospitals for margin positivity at resection, as well as potentially modifiable risk factors. The nomogram created in this model allows for the evaluation of observed and expected event rates for individual hospitals, providing a hospital self-assessment tool for identifying targets for improvement.

Entities:  

Mesh:

Year:  2013        PMID: 23803722      PMCID: PMC3947615          DOI: 10.1001/jamasurg.2013.2136

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  31 in total

1.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

Review 3.  Provider volume and outcomes for oncological procedures.

Authors:  S D Killeen; M J O'Sullivan; J C Coffey; W O Kirwan; H P Redmond
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

4.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

5.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

6.  Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

7.  Long-term survival and recurrence outcomes following surgery for distal rectal cancer.

Authors:  Eric J Silberfein; Kiran M Kattepogu; Chung-Yuan Hu; John M Skibber; Miguel A Rodriguez-Bigas; Barry Feig; Prajnan Das; Sunil Krishnan; Christopher Crane; Scott Kopetz; Cathy Eng; George J Chang
Journal:  Ann Surg Oncol       Date:  2010-06-15       Impact factor: 5.344

8.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

9.  The effect of hospital volume on cancer control after radical prostatectomy.

Authors:  L M Ellison; B J Trock; N R Poe; A W Partin
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

10.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

View more
  18 in total

1.  Disparities in care for patients with curable hepatocellular carcinoma.

Authors:  Richard S Hoehn; Dennis J Hanseman; Peter L Jernigan; Koffi Wima; Audrey E Ertel; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

2.  Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; Emmanuel Gabriel; Steven J Nurkin
Journal:  Int J Surg       Date:  2016-02-21       Impact factor: 6.071

3.  Recommendations for follow-up of colorectal cancer survivors.

Authors:  R Vera; J Aparicio; F Carballo; M Esteva; E González-Flores; J Santianes; F Santolaya; J M Fernández-Cebrián
Journal:  Clin Transl Oncol       Date:  2019-02-14       Impact factor: 3.405

4.  High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action.

Authors:  Aaron S Rickles; David W Dietz; George J Chang; Steven D Wexner; Mariana E Berho; Feza H Remzi; Frederick L Greene; James W Fleshman; Maher A Abbas; Walter Peters; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

5.  Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.

Authors:  Nader N Massarweh; Chung-Yuan Hu; Y Nancy You; Brian K Bednarski; Miguel A Rodriguez-Bigas; John M Skibber; Scott B Cantor; Janice N Cormier; Barry W Feig; George J Chang
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

6.  Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer.

Authors:  Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2017-07-12       Impact factor: 4.330

7.  Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis.

Authors:  Yufeng Wang; Jiayuan Wu; Hairong He; Huan Ma; Liren Hu; Jiyu Wen; Jun Lyu
Journal:  Int J Colorectal Dis       Date:  2020-02-20       Impact factor: 2.571

8.  Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis.

Authors:  Lawrence Lee; Justin Kelly; George J Nassif; Sam B Atallah; Matthew R Albert; Ravi Shridhar; John R T Monson
Journal:  J Gastrointest Surg       Date:  2017-08-17       Impact factor: 3.452

9.  Identifying Performance Outliers for Stroke Care Based on Composite Score of Process Indicators: an Observational Study in China.

Authors:  Chao Wang; Shaofei Su; Xi Li; Jingkun Li; Xiaoqiang Bao; Meina Liu
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

Review 10.  Advances in the care of patients with mucinous colorectal cancer.

Authors:  Niek Hugen; Gina Brown; Robert Glynne-Jones; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.